These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1688748)
21. [Prostate-specific antigen in prostatic pathology]. Teillac P; Peyret C; Leroy M; Najean Y; Le Duc A Ann Urol (Paris); 1988; 22(3):193-6. PubMed ID: 2456712 [TBL] [Abstract][Full Text] [Related]
22. [The value of the serum level of the prostate-specific antigen in prostatic pathology]. Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713 [TBL] [Abstract][Full Text] [Related]
23. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. Yu H; Diamandis EP J Urol; 1995 Mar; 153(3 Pt 2):1004-8. PubMed ID: 7531781 [TBL] [Abstract][Full Text] [Related]
24. Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Ferro MA; Barnes I; Roberts JB; Smith PJ Br J Urol; 1987 Jul; 60(1):69-73. PubMed ID: 2441790 [TBL] [Abstract][Full Text] [Related]
25. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186 [TBL] [Abstract][Full Text] [Related]
26. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis). Lokant MT; Naz RK Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795 [TBL] [Abstract][Full Text] [Related]
27. The effects of transurethral prostatectomy on serum prostate specific antigen. Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243 [TBL] [Abstract][Full Text] [Related]
28. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I Am J Med; 1998 Jun; 104(6):517-25. PubMed ID: 9674713 [TBL] [Abstract][Full Text] [Related]
29. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Armitage TG; Cooper EH; Newling DW; Robinson MR; Appleyard I Br J Urol; 1988 Dec; 62(6):584-9. PubMed ID: 2464397 [TBL] [Abstract][Full Text] [Related]
30. [Prostate-specific antigen. A new marker of prostatic pathology]. Boccon-Gibod L; Géraud M; Dugué MA Ann Urol (Paris); 1988; 22(3):206-10. PubMed ID: 2456714 [TBL] [Abstract][Full Text] [Related]
31. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis. Lein M; Jung K; Hammerer P; Graefen M; Semjonow A; Stieber P; Ossendorf M; Luboldt HJ; Brux B; Stephan C; Schnorr D; Loening SA Prostate; 2001 May; 47(2):77-84. PubMed ID: 11340629 [TBL] [Abstract][Full Text] [Related]
32. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. Nurmikko P; Pettersson K; Piironen T; Hugosson J; Lilja H Clin Chem; 2001 Aug; 47(8):1415-23. PubMed ID: 11468231 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody to the prostate specific antigen. Donn F; Bruns T; von Meyerrinck L; Augustin C; Schulz M; Klosterhalfen H; Schmoldt A Andrologia; 1990; 22 Suppl 1():44-55. PubMed ID: 1720289 [TBL] [Abstract][Full Text] [Related]
34. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054 [TBL] [Abstract][Full Text] [Related]
35. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project. Kane RA; Littrup PJ; Babaian R; Drago JR; Lee F; Chesley A; Murphy GP; Mettlin C Cancer; 1992 Mar; 69(5):1201-7. PubMed ID: 1371234 [TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609 [TBL] [Abstract][Full Text] [Related]
37. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Ferguson RA; Yu H; Kalyvas M; Zammit S; Diamandis EP Clin Chem; 1996 May; 42(5):675-84. PubMed ID: 8653891 [TBL] [Abstract][Full Text] [Related]
38. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease. Buamah PK; Johnson P; Skillen AW Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396 [TBL] [Abstract][Full Text] [Related]
39. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Sinha AA; Wilson MJ; Gleason DF Cancer; 1987 Sep; 60(6):1288-93. PubMed ID: 2441840 [TBL] [Abstract][Full Text] [Related]
40. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]